GET DAILY SIGNALSWhy Is Aveanna Healthcare Holdings (AVAH) Stock Down -2.93% Today?
Key Takeaways
- AVAH shares were down about 2.93%, or $0.40, to $13.27 in Friday's session, slipping from a prior close of $13.67.
- The decline is primarily profit-taking after a sharp, midterm-election-driven rally that briefly pushed the stock to the top of its 52-week range.
- No single company-specific catalyst drove the move; the pullback reflects a broader cooling in home health and healthcare services names after their post-election surge.
- The stock remains near its 52-week high and is still up sharply on a year-to-date basis, keeping valuation-sensitive sellers active.
- Traders are now positioning ahead of the company's third-quarter earnings, scheduled for release before the market opens on Nov. 12, 2026.
- For more detail on valuation, upcoming results, and outlook, explore Tickeron's Price Targets, Earnings, and Forecast pages.
- Explore Trending AI Robots to see which AI-driven trading strategies are currently the strongest performers across the market.
Opening Summary
Aveanna Healthcare Holdings, Inc. (AVAH), an Atlanta-based diversified home care platform that provides pediatric and adult healthcare services across the United States, saw its shares decline roughly 2.93% on Friday. The stock traded at approximately $13.27, down $0.40 from the previous session's close of $13.67. The move extends a modest pullback that began after the company's stock spiked in the immediate aftermath of the midterm elections, with markets attributing the slide to profit-taking rather than any new company-specific news.
Post-Election Profit-Taking Weighs on Shares
The dominant driver behind the decline is a unwind of the enthusiasm that followed the Nov. 3 midterm elections. Home health and healthcare services stocks rallied sharply on the view that the election outcome could be favorable for Medicaid reimbursement and Affordable Care Act-backed coverage — both central revenue drivers for providers like AVAH. The stock jumped more than 7% in a single session as investors repriced the potential policy tailwinds.
In the sessions since, traders have been locking in those gains. Friday's slide, together with the prior day's retreat, reflects a natural give-back as the election-related optimism cools and investors reassess how much of the policy benefit is already reflected in the share price. The stock remains within sight of its 52-week high, which has made it an easy candidate for rotation out of recent outperformers.
Sector Rotation and Valuation Sensitivity
The pullback also aligns with broader rotation within the medical care facilities and home health segment. After a strong run, high-beta healthcare services names have faced selective selling as investors weigh rich valuations against the timeline for any concrete policy changes. AVAH, which carries an elevated beta relative to the broader market, tends to amplify sector moves in both directions, making its declines more pronounced during risk-off stretches.
Market Context and Trading Activity
The stock's recent path has been volatile: a rapid advance toward its 52-week high was followed by two consecutive down sessions. The shares are still well above their 52-week low, underscoring how far the name has climbed over the past year. Trading activity picked up notably during the election-driven surge and has remained choppy since, consistent with active repositioning ahead of the company's quarterly report rather than a shift in the fundamental outlook.
Broader equity indices have been comparatively steady, indicating that Friday's move was more idiosyncratic to the healthcare services complex and to AVAH's recent momentum than a market-wide selloff.
What Comes Next for AVAH
Investors' attention now turns to the company's third-quarter results, due before the market opens on Nov. 12, 2026. Analysts will be focused on volume trends across private duty services, home health and hospice, and medical solutions, as well as any commentary on state rate wins and reimbursement dynamics. The company has a track record of beating consensus earnings estimates, but the recent run-up raises the bar for the market reaction. Key risks include potential shifts in Medicaid and Medicare reimbursement policy, labor cost pressures, and the pace of deleveraging. The direction of the stock in the near term is likely to hinge on whether the upcoming report and guidance justify the valuation that the post-election rally created.
Trending AI Robots
Tickeron offers hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and the symbols they trade, giving investors a range of approaches to explore. Visit the Trending AI Robots page to see which strategies are leading the market right now.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AVAH in upward trend: price rose above 50-day moving average on October 29, 2026
AVAH moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 36 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on AVAH as a result. In 83 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
The Moving Average Convergence Divergence (MACD) for AVAH just turned positive on October 20, 2026. Looking at past instances where AVAH's MACD turned positive, the stock continued to rise in 35 of 40 cases over the following month. The odds of a continued upward trend are 88%.
The 10-day moving average for AVAH crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 71%.
Following a +8.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVAH advanced for three days, in 198 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 141 of 177 cases where AVAH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
Bearish Trend Analysis
The 10-day RSI Indicator for AVAH moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 26 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVAH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
AVAH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. AVAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.361) is normal, around the industry mean (203.977). P/E Ratio (10.278) is within average values for comparable stocks, (20.904). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.097) among similar stocks. P/S Ratio (1.223) is also within normal values, averaging (2.688).
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry HospitalNursingManagement
Advertisement